STOCK TITAN

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
AI

Quest Diagnostics (NYSE: DGX) has announced a strategic collaboration with Google Cloud to enhance its data management and customer experience using generative AI technology. The partnership, announced on March 18, 2025, will utilize Google's Agentspace platform to connect employees and customers with enterprise-wide knowledge and automate complex tasks.

Quest will implement Google Cloud's data analytics and AI capabilities across various operations, including R&D, customer experience, and operations, with robust data privacy safeguards. The collaboration aims to help patients better understand their laboratory data and assist physicians in providing more personalized care.

With Quest processing over 200 million test requisitions and managing more than 80 billion datapoints in 2024, the partnership will leverage Google Cloud's HIPAA-compliant infrastructure and secure data storage. This initiative builds upon Quest's existing AI and automation implementations in areas such as microbiology, cytology testing, specimen processing, and customer service.

Quest Diagnostics (NYSE: DGX) ha annunciato una collaborazione strategica con Google Cloud per migliorare la gestione dei dati e l'esperienza del cliente utilizzando la tecnologia dell'IA generativa. La partnership, annunciata il 18 marzo 2025, utilizzerà la piattaforma Agentspace di Google per connettere dipendenti e clienti con conoscenze a livello aziendale e automatizzare compiti complessi.

Quest implementerà le capacità di analisi dei dati e IA di Google Cloud in diverse operazioni, tra cui ricerca e sviluppo, esperienza del cliente e operazioni, con robuste misure di protezione della privacy dei dati. La collaborazione mira ad aiutare i pazienti a comprendere meglio i loro dati di laboratorio e ad assistere i medici nel fornire cure più personalizzate.

Con Quest che gestisce oltre 200 milioni di richieste di test e oltre 80 miliardi di punti dati nel 2024, la partnership sfrutterà l'infrastruttura conforme all'HIPAA di Google Cloud e lo stoccaggio sicuro dei dati. Questa iniziativa si basa sulle implementazioni esistenti di IA e automazione di Quest in aree come microbiologia, test citologici, elaborazione dei campioni e servizio clienti.

Quest Diagnostics (NYSE: DGX) ha anunciado una colaboración estratégica con Google Cloud para mejorar la gestión de datos y la experiencia del cliente utilizando tecnología de IA generativa. La asociación, anunciada el 18 de marzo de 2025, utilizará la plataforma Agentspace de Google para conectar a empleados y clientes con conocimientos a nivel empresarial y automatizar tareas complejas.

Quest implementará las capacidades de análisis de datos e IA de Google Cloud en diversas operaciones, incluyendo I+D, experiencia del cliente y operaciones, con sólidas medidas de privacidad de datos. La colaboración tiene como objetivo ayudar a los pacientes a comprender mejor sus datos de laboratorio y asistir a los médicos en la prestación de una atención más personalizada.

Con Quest procesando más de 200 millones de solicitudes de pruebas y gestionando más de 80 mil millones de puntos de datos en 2024, la asociación aprovechará la infraestructura conforme a HIPAA de Google Cloud y el almacenamiento seguro de datos. Esta iniciativa se basa en las implementaciones existentes de IA y automatización de Quest en áreas como microbiología, pruebas citológicas, procesamiento de muestras y servicio al cliente.

퀘스트 진단(Quest Diagnostics) (NYSE: DGX)구글 클라우드(Google Cloud)와 협력하여 생성적 AI 기술을 활용한 데이터 관리 및 고객 경험 향상을 위한 전략적 협업을 발표했습니다. 이 파트너십은 2025년 3월 18일에 발표되었으며, 구글의 에이전트스페이스 플랫폼을 활용하여 직원과 고객을 기업 전반의 지식과 연결하고 복잡한 작업을 자동화할 것입니다.

퀘스트는 연구개발, 고객 경험 및 운영을 포함한 다양한 운영에서 구글 클라우드의 데이터 분석 및 AI 기능을 구현하며, 강력한 데이터 프라이버시 보호 조치를 갖출 것입니다. 이 협업은 환자들이 자신의 실험실 데이터를 더 잘 이해하도록 돕고, 의사들이 보다 개인화된 치료를 제공하는 데 도움을 주는 것을 목표로 합니다.

2024년 퀘스트가 2억 건 이상의 검사 요청을 처리하고 800억 개 이상의 데이터 포인트를 관리함에 따라, 이 파트너십은 구글 클라우드의 HIPAA 준수 인프라와 안전한 데이터 저장을 활용할 것입니다. 이 이니셔티브는 미생물학, 세포학 테스트, 샘플 처리 및 고객 서비스와 같은 분야에서 퀘스트의 기존 AI 및 자동화 구현을 기반으로 합니다.

Quest Diagnostics (NYSE: DGX) a annoncé une collaboration stratégique avec Google Cloud pour améliorer la gestion des données et l'expérience client en utilisant la technologie de l'IA générative. Ce partenariat, annoncé le 18 mars 2025, utilisera la plateforme Agentspace de Google pour connecter les employés et les clients avec des connaissances à l'échelle de l'entreprise et automatiser des tâches complexes.

Quest mettra en œuvre les capacités d'analyse de données et d'IA de Google Cloud dans diverses opérations, y compris la recherche et développement, l'expérience client et les opérations, avec des mesures de protection de la vie privée des données robustes. La collaboration vise à aider les patients à mieux comprendre leurs données de laboratoire et à aider les médecins à fournir des soins plus personnalisés.

Avec Quest traitant plus de 200 millions de demandes de tests et gérant plus de 80 milliards de points de données en 2024, le partenariat tirera parti de l'infrastructure conforme à la HIPAA de Google Cloud et du stockage sécurisé des données. Cette initiative s'appuie sur les mises en œuvre existantes de l'IA et de l'automatisation de Quest dans des domaines tels que la microbiologie, les tests cytologiques, le traitement des échantillons et le service client.

Quest Diagnostics (NYSE: DGX) hat eine strategische Zusammenarbeit mit Google Cloud angekündigt, um das Datenmanagement und die Kundenerfahrung mithilfe von generativer KI-Technologie zu verbessern. Die Partnerschaft, die am 18. März 2025 bekannt gegeben wurde, wird die Agentspace-Plattform von Google nutzen, um Mitarbeiter und Kunden mit unternehmensweitem Wissen zu verbinden und komplexe Aufgaben zu automatisieren.

Quest wird die Datenanalyse- und KI-Funktionen von Google Cloud in verschiedenen Bereichen implementieren, darunter Forschung und Entwicklung, Kundenerfahrung und Betrieb, mit robusten Datenschutzmaßnahmen. Die Zusammenarbeit zielt darauf ab, Patienten zu helfen, ihre Laborwerte besser zu verstehen und Ärzten zu helfen, eine individuellere Versorgung zu bieten.

Da Quest im Jahr 2024 über 200 Millionen Testanforderungen bearbeitet und mehr als 80 Milliarden Datenpunkte verwaltet, wird die Partnerschaft die HIPAA-konforme Infrastruktur und den sicheren Datenspeicher von Google Cloud nutzen. Diese Initiative baut auf den bestehenden KI- und Automatisierungsimplementierungen von Quest in Bereichen wie Mikrobiologie, zytologische Tests, Probenverarbeitung und Kundenservice auf.

Positive
  • First national laboratory provider to implement generative AI across multiple operational areas
  • Strategic enhancement of hybrid cloud capabilities and data analytics
  • Potential for improved operational efficiency and customer service through AI automation
  • Access to Google Cloud's advanced AI technology and HIPAA-compliant infrastructure
Negative
  • Significant investment in new technology infrastructure required
  • Potential implementation and integration challenges with existing systems
  • Data privacy and security risks associated with cloud-based solutions

Insights

Quest Diagnostics' strategic collaboration with Google Cloud represents a significant digital transformation initiative poised to enhance multiple aspects of Quest's business operations. With the company processing over 200 million test requisitions and managing 80 billion datapoints annually, this partnership addresses critical data infrastructure needs at scale.

The implementation of Google's generative AI technologies, particularly Google Agentspace, positions Quest to potentially realize substantial operational efficiencies across R&D, customer experience, and administrative functions. While the announcement lacks specific financial projections or implementation costs, the focus on streamlining data management and analytics suggests potential long-term margin improvements through reduced operational overhead and enhanced productivity.

This partnership aligns with Quest's existing strategy of deploying AI and automation, where they've already demonstrated success in areas like microbiology testing and customer service. The Google Cloud collaboration represents a significant expansion of these capabilities, potentially creating competitive differentiation in the diagnostics information services market through personalized patient experiences and improved provider interactions.

Particularly noteworthy is the dual focus on operational efficiency and customer experience enhancement—suggesting Quest is pursuing both cost optimization and revenue growth opportunities through this technology initiative. The expansion of their hybrid cloud strategy indicates Quest is taking a measured approach to digital transformation while maintaining appropriate security controls for sensitive healthcare data.

Quest's Google Cloud partnership represents a sophisticated implementation of enterprise-grade generative AI that goes beyond typical healthcare applications. By deploying Google Agentspace—a platform for connecting employees and customers with enterprise-wide knowledge—Quest is positioning itself at the forefront of AI adoption in diagnostic services.

The technical architecture described suggests a comprehensive data strategy combining cloud storage, analytics, and AI capabilities within a HIPAA-compliant framework. This approach should enable Quest to transform its massive dataset (80 billion datapoints) from a static resource into an actionable intelligence layer that can drive personalized experiences.

From an implementation perspective, Quest's existing success with AI in microbiology, cytology, and customer service provides a foundation for this expanded initiative. The hybrid cloud strategy mentioned indicates Quest is taking a pragmatic approach—likely maintaining sensitive workloads on-premises while leveraging Google Cloud for scalable computing and advanced AI capabilities.

The potential technical applications mentioned—particularly helping patients glean personalized health insights from laboratory data and empowering physicians with enhanced laboratory insights—represent high-value use cases that could differentiate Quest's services. These capabilities typically require sophisticated data pipelines, semantic understanding of medical terminology, and context-aware AI models—all areas where Google's technology stack excels.

While implementation challenges are inevitable with enterprise-scale AI deployments, Google's experience with healthcare data and Quest's existing AI implementations suggest the partnership has strong technical foundations for success.

SUNNYVALE, Calif. and SECAUCUS, N.J., March 18, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a collaboration with Google Cloud to streamline Quest's data management, improve data analytics, and personalize the experiences Quest delivers to patients, providers and other customers.

To do so, Quest Diagnostics will use Google Cloud's data analytics and generative AI (gen AI) technologies, including Google Agentspace, a platform that uses gen AI to connect employees and customers with enterprise-wide knowledge and automate complex tasks through intelligent, customizable agents. The collaboration is one of the first by a national laboratory provider to use these technologies across a range of operations and administrative areas like R&D, customer experience and operations—with data privacy and security safeguards implemented.

"We are excited about the potential to innovate and personalize the services we bring to our patients, clients, and employees," said Murali Balakumar, senior vice president and chief information and digital officer, Quest Diagnostics. "Google Cloud provides a best-in-class platform for securely streamlining and integrating data to generate novel insights and improve productivity. Google Cloud's generative AI capabilities can help dismantle care roadblocks by personalizing the way patients and providers interact with us, improving care access, customer experiences, and quality."

The collaboration will involve streamlining Quest's systems to improve data quality, management, and security. The parties will also explore the use of gen AI in multiple areas, including improving patient engagement by helping patients and consumers glean personalized health insights from their laboratory data, and empowering physicians with laboratory insights and other data to enhance care for the individual patient.

"Working with Google will help us create new capabilities for serving patients, healthcare providers, and other customers," said Mark S. Clare, vice president and chief data officer, Quest Diagnostics. "Data management has gone through significant generational changes in recent years and is only accelerating today with generative AI. Quest's relationship with Google will enable Quest to capitalize on the rapidly changing technology landscape to evolve customer insights in a responsible, trusted and secure manner."

"This collaboration with Quest Diagnostics marks an important moment in healthcare innovation," said Thomas Kurian, CEO, Google Cloud. "By combining Google Cloud's cutting-edge AI and data analytics capabilities, with Quest's vast network and deep healthcare expertise, we're helping improve diagnostics and patient care. Together, we're paving the way for a future where healthcare is more personalized, proactive, and accessible for everyone."

Quest expects the relationship with Google to strengthen its hybrid cloud strategy by growing data and AI capabilities and improving productivity. In 2024, Quest fulfilled more than 200 million test requisitions (orders for tests) and managed over 80 billion datapoints. Access and use of patient data will be protected through implementation of Google Cloud's HIPAA-compliant infrastructure and secure data storage, and Quest's security and privacy controls, and processes.

The Google relationship builds on Quest's strategy to deploy AI and automation technologies to improve productivity, service, quality and innovation. The company has successfully deployed AI and automation in several areas of its organization, including microbiology and cytology testing, specimen processing and customer service.

About Google Cloud
Google Cloud is the new way to the cloud, providing AI, infrastructure, developer, data, security, and collaboration tools built for today and tomorrow. Google Cloud offers a powerful, fully integrated and optimized AI stack with its own planet-scale infrastructure, custom-built chips, generative AI models and development platform, as well as AI-powered applications, to help organizations transform. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-collaborate-with-google-cloud-to-streamline-data-and-personalize-customer-experiences-using-generative-ai-302403989.html

SOURCE Google Cloud

FAQ

What are the main objectives of Quest Diagnostics' collaboration with Google Cloud?

The collaboration aims to streamline data management, improve analytics, and personalize experiences for patients and providers using Google Cloud's generative AI and data analytics technologies.

How many test requisitions and datapoints did Quest Diagnostics (DGX) handle in 2024?

Quest processed over 200 million test requisitions and managed more than 80 billion datapoints in 2024.

How will Quest Diagnostics ensure data security in this Google Cloud partnership?

Quest will implement Google Cloud's HIPAA-compliant infrastructure, secure data storage, and maintain its own security and privacy controls and processes.

In which operational areas has DGX already implemented AI and automation?

Quest has deployed AI and automation in microbiology, cytology testing, specimen processing, and customer service.

What specific Google Cloud technology will Quest Diagnostics use in this collaboration?

Quest will use Google Agentspace, a platform that uses generative AI to connect employees and customers with enterprise-wide knowledge and automate complex tasks.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

18.49B
110.45M
0.44%
93.75%
2.31%
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS